stockrowTrulieve Cannabis Corp.
TRLV Healthcare Drug Manufacturers Specialty & Generic
Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- −20.1%
- EPS
- −2,391.1%
- Free cash flow
- +24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow TRLV
Alert me
Trulieve Cannabis Corp. (TRLV) Gross margin
Trulieve Cannabis Corp.'s gross margin over the twelve months to 30 September 2026 was 60.6%, up 0.4 percentage points from fiscal 2025 (60.2%). Over the past ten years it has ranged from 52.1% (fiscal 2023) to 74.1% (fiscal 2020); the current reading is higher than 50% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 60.2% | (0.11) |
| FY2024 | 60.3% | 8.19 |
| FY2023 | 52.1% | (4.44) |
| FY2022 | 56.6% | (4.23) |
| FY2021 | 60.8% | (13.29) |
| FY2020 | 74.1% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 64.3% | 4.40 |
| Jun 2026 | 59.9% | 0.59 |
| Mar 2026 | 59.3% | (0.44) |
| Dec 2025 | 59.8% | 0.81 |
| 19 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | 97.9% |
| XERS Xeris Biopharma Holdings, Inc. compare | 87.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 61.1% |
| TRLV Trulieve Cannabis Corp. | 60.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| ALVO Alvotech compare | 42.7% |
| PRGO Perrigo Company plc compare | 32.3% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TRLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement